Dewpoint Therapeutics

Dewpoint Therapeutics | 2,925 followers on LinkedIn. Dewpoint is translating new insights about biomolecular condensates into treatments for the toughest diseases. | Dewpoint Therapeutics is the first company founded to apply the emerging discipline of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions have pathways that are regulated by condensates or arise from the dysfunction of condensates — including cancer, neurodegeneration, and metabolic disease. Dewpoint scientists are working in Boston, MA, and Dresden, Germany, to translate condensate biology into treatments for the toughest diseases.